Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012"

Paolo Ascierto 1, * Antonio Grimaldi 1 Nicolas Acquavella 2 Lorenzo Borgognoni 3 Luana Calabrò 4 Natale Cascinelli 5 Alessandra Cesano 6 Michele Del Vecchio 7 Alexander Eggermont 8 Mark Faries 9 Soldano Ferrone 10 Bernard Fox 11, 12 Thomas Gajewski 13 Jérôme Galon 14 Sacha Gnjatic 15 Helen Gogas 16 Mohammed Kashani-Sabet 17 Howard Kaufman 18 James Larkin 19 Roger Lo 20 Alberto Mantovani 21 Kim Margolin 22 Cornelis Melief 23 Grant Mcarthur 24 Giuseppe Palmieri 25 Igor Puzanov 26 Antoni Ribas 27 Barbara Seliger 28 Jeff Sosman 29 Peter Suenaert 30 Ahmad Tarhini 31 Giorgio Trinchieri 32 Fernando Vidal-Vanaclocha 33 Ena Wang 34 Gennaro Ciliberto 1 Nicola Mozzillo 1 Francesco Marincola 35 Magdalena Thurin 36
Abstract : Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma. The possibility to use these drugs in combination to improve responses to overcome the resistance, to potentiate the action of immune system with the new immunomodulating antibodies, and identification of biomarkers that can predict the response to a particular therapy represent new concepts and approaches in the clinical management of melanoma. The third "Melanoma Research: "A bridge from Naples to the World" meeting, shortened as "Bridge Melanoma Meeting" took place in Naples, December 2 to 4th, 2012. The four topics of discussion at this meeting were: advances in molecular profiling and novel biomarkers, combination therapies, novel concepts toward integrating biomarkers and therapies into contemporary clinical management of patients with melanoma across the entire spectrum of disease stage, and the knowledge gained from the biology of tumor microenvironment across different tumors as a bridge to impact on prognosis and response to therapy in melanoma. This international congress gathered more than 30 international faculty members who in an interactive atmosphere which stimulated discussion and exchange of their experience regarding the most recent advances in research and clinical management of melanoma patients.
Type de document :
Article dans une revue
Journal of Translational Medicine, BioMed Central, 2013, 11 (1), pp.137. 〈10.1186/1479-5876-11-137〉
Liste complète des métadonnées

Littérature citée [117 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00834025
Contributeur : Ed. Bmc <>
Soumis le : jeudi 13 juin 2013 - 21:03:37
Dernière modification le : mercredi 20 décembre 2017 - 12:00:02
Document(s) archivé(s) le : samedi 14 septembre 2013 - 04:17:08

Fichiers

Identifiants

Collections

Citation

Paolo Ascierto, Antonio Grimaldi, Nicolas Acquavella, Lorenzo Borgognoni, Luana Calabrò, et al.. Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012". Journal of Translational Medicine, BioMed Central, 2013, 11 (1), pp.137. 〈10.1186/1479-5876-11-137〉. 〈inserm-00834025〉

Partager

Métriques

Consultations de la notice

328

Téléchargements de fichiers

361